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Abstract
Purpose To perform a systematic review on the epide-
miology, the health-related quality of life (HRQoL) and
economic burden of binge eating disorder (BED).
Methods A systematic literature search of English-lan-
guage articles was conducted using Medline, Embase,
PsycINFO, PsycARTICLES, Academic Search Complete,
CINAHL Plus, Business Source Premier and Cochrane
Library. Literature search on epidemiology was limited to
studies published between 2009 and 2013. Cost data were
inflated and converted to 2012 US$ purchasing power
parities. All of the included studies were assessed for
quality.
Results Forty-nine articles were included. Data on epi-
demiology were reported in 31, HRQoL burden in 16, and
economic burden in 7 studies. Diagnosis of BED was made
using 4th Edition of The Diagnostic and Statistical Manual
of Mental Disorders (DSM-IV) criteria in 46 studies.
Lifetime prevalence of BED was 1.1–1.9 % in the general
population (DSM-IV). BED was associated with significant
impairment in aspects of HRQoL relating to both physical
and mental health; the Short Form 36 Physical and Mental
Component Summary mean scores varied between 31.1 to
47.3 and 32.0 to 49.8, respectively. Compared to individ-
uals without eating disorder, BED was related to increased
healthcare utilization and costs. Annual direct healthcare
costs per BED patient ranged between $2,372 and $3,731.
Conclusions BED is a serious eating disorder that impairs
HRQoL and is related to increased healthcare utilization
and healthcare costs. The limited literature warrants further
research, especially to better understand the long-term
HRQoL and economic burden of BED.
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Introduction
Binge eating disorder (BED) is a psychiatric disorder,
characterized by recurrent binge eating episodes which are
not followed by inappropriate compensatory behaviors.
BED appears to affect a broader spectrum of the population
than anorexia nervosa (AN) and bulimia nervosa (BN) [1–
4], resulting in a clinically significant disorder [5].
BED was originally introduced in the 4th Edition of The
Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV) as a sub-category of eating disorders not
otherwise specified (EDNOS) [6]. In the new DSM-5,
published in May 2013, BED was included as a full diag-
nostic entity [7]. In the DSM-IV, for a provisional diag-
nosis of BED, binge eating must occur on at least 2 days
per week over a 6-month period [6]. In contrast, according
to the new DSM-5 criteria, BED is characterized by at least
one binge eating episode per week for three months [7].
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The aim of this study is to undertake a systematic review
of the published literature on the epidemiology, HRQoL
and economic burden of BED. To our knowledge, no
comprehensive review encompassing these topics has been
published to date. However, this information consolidated
in a single literature review provides a holistic overview of
the public health importance of BED.
Materials and methods
This review of evidence on the burden of BED was a part
of a comprehensive literature review on the epidemiology,
and the HRQoL and economic burden of eating disorders.
A systematic literature search was conductedin July 2013
using Medline and Embase (via Scopus), PsycINFO, Psy-
cARTICLES, Academic Search Complete, CINAHL Plus,
Business Source Premier (via Ebsco Host) and Cochrane
Library. Search terms were combinations of terms related
to the disease (BED, AN, BN and EDNOS), epidemiology
(prevalence, incidence and mortality), HRQoL burden
(quality of life, health burden, humanistic burden, quality
adjusted life years and disability adjusted life years) and
economic burden (direct healthcare costs, direct patient and
caregiver cost, wider societal cost). For case of studies
related to HRQoL and/or economic burden, there were no
pre-defined publication date limits. To get up to date epi-
demiological data, literature search on epidemiology was
limited to studies published between 2009 and 2013.
Specification of the review protocol is provided in Online
Resource 1.
Search results were considered in two steps. Initially,
titles and abstracts of all articles were screened using the
following inclusion criteria: (1) the article was written in
English; (2) the article was related to eating disorders;
and (3) the article studied the epidemiology, HRQoL
burden and/or economic burden of eating disorders. Those
articles deemed relevant were analyzed in full text. Dur-
ing the full text review only publications in which BED
was defined using either the DSM-IV or DSM-5 criteria
(proposed or published), and BED sample was clearly
separated from other eating disorders were included;
reasons for exclusion were: (1) the article was not written
in English; (2) the article was not published in peer-
reviewed journals; (3) the article was editorial, letter, case
report or review; (4) the article was not specific to BED;
or (5) the article had other objective than studying the
epidemiology, HRQoL and/or economic burden of BED.
References of relevant articles were screened for addi-
tional eligible studies. Literature screening was conducted
by two reviewers independently; disagreements were
resolved by the principal researcher.
Data extraction focused on and was limited to findings
relevant to the research topic. The following information
was extracted from each study: (1) first author and year of
publication; (2) country; (3) study design; (4) study year;
(5) included eating disorder(s); (6) diagnostic method and
criteria for BED; (7) characteristics of study sample
[sample size, % of female, mean age, mean body mass
index (BMI)]; (8) epidemiological data [incidence, prev-
alence (lifetime, 12-month, point), mortality, suicide
(ideation, attempt)]; (9) data on the HRQoL burden of
BED (HRQoL instrument, HRQoL data) (10) data on
healthcare utilization of BED patients (data source,
resource utilization categories, main findings); and (11)
data on healthcare costs and/or societal costs related to
BED (perspective of the analysis, data source, year of
pricing, cost categories, cost data). For interventional
studies, in which HRQoL was assessed, only the baseline
HRQoL data were extracted as this review investigated the
association between BED and patient’s HRQoL and not
the efficacy/effectiveness of different interventions on
HRQoL in BED.
In this review, prevalence and incidence were defined as
follows: incidence as the number of new cases of a disorder
in the population over a specified period related to the
number of persons at risk at the beginning of the period
(cumulative incidence) or to the person-time of observation
(incidence rate); point prevalence as the proportion of
persons affected with the disorder at a specific point in
time; 12-month prevalence rate as the point prevalence plus
the annual cumulative incidence (the proportion of people
with new cases in the following year); lifetime prevalence
as the proportion of people that had the disorder at any
point in their life.
In order to compare cost data across studies, costs were
extrapolated to annual costs per patient and were inflated to
the year of 2012 using country specific gross domestic
product (GDP) deflators, and converted into United States
(US) dollars ($), using purchasing power parities. If the
year of pricing was not referenced, then the midpoint in the
observation period was assumed as the base year. If no
observation period was reported, the year of publication
was adopted.
Quality assessment of the included studies was per-
formed using the strengthening the reporting of observa-
tional studies in epidemiology (STROBE) checklist for
cohort, case–control, and cross-sectional studies [8]. The
results for each study were summarized as the percentage
of the fulfilled criteria. STROBE criteria that were not
applicable to a study were excluded from the quality
assessment. All studies were independently assessed by
two researchers, disagreements were resolved by the prin-
cipal researcher.




The database search resulted in 7,211 hits. Screening of
titles and abstracts identified 540 potentially eligible arti-
cles. Two additional records were identified through hand
search of the references of relevant articles. After the
review of relevant full text articles, 49 studies were
included in this systematic review. The flow diagram of the
systematic literature search, based on the preferred
reporting items for systematic reviews and meta-analyses
(PRISMA) template [9], is presented in Fig. 1.
Most studies (n = 40) were cross-sectional [2–4, 19–
55], 7 longitudinal [10–12, 15–18], and 2 were database
analyses [13, 14]. Included studies originated from 23
countries, with over half (n = 25) conducted in the US.
The sample sizes of the included studies ranged from 31
[19] to 77,807 [12], with a mean ages from 13.0 [16] to
49.8 [20] years. Many studies only included females
(n = 18) but in those including both sexes, females were
over-represented. Diagnosis of BED was made using
DSM-IV criteria in 44 [2–4, 10, 12–15, 17–20, 22–30,
32–41, 43–55], using the proposed DSM-5 criteria in 3
[11, 16, 31], and using both DSM-IV and the proposed
DSM-5 criteria in 2 studies [21, 42]. The general char-
acteristics of the reviewed studies are presented in Online
Resource 2.
Included studies (n = 49) fulfilled between 26.5 [21]
and 84.4 % [3] of the STROBE criteria. Details of the
quality assessment are provided in Online Resource 3.
Epidemiology
Only one study reported incidence rate for BED [16]. A
sample of 496 adolescent females over an 8-year period
found the incidence of BED (DSM-5) to be 343 per
100,000 person-years [16].
Fig. 1 The flow diagram of the systematic literature search. BED binge eating disorder. HRQoL health-related quality of life
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Point prevalence rate for BED was reported in 22 studies
[12, 14, 20–39], 12-month prevalence rate in 4 studies [2–
4, 13] and lifetime prevalence rate in 11 studies [2–4, 13,
16, 17, 21, 36, 40–42]. Detailed information on the
reported prevalence rates are presented in Online Resource
2. Point prevalence rates, not limited to population-based
estimates varied between 0.1 % (in a sample of pregnant
women, 6–12 months prior pregnancy) [27] and 34.1 % (in
a sample with type 2 diabetes) [20] using DSM-IV criteria,
and 0.6 % (in a sample of female high school and uni-
versity students) [31] to 1.7 % (in a sample of first degree
relatives of BED patients) [21] using the proposed DSM-5
criteria. The 12-month prevalence rate of BED, not limited
to population-based estimates ranged between 0.1 % (in a
large community sample of people over 18 years of age)
[3] and 1.1 % (in a sample of Latino) [13] using DSM-IV
criteria. Lifetime prevalence for BED, not limited to pop-
ulation-based estimates was 0.17 % (in a sample of adult
female twins) [42] to 8.8 % (in a sample of outpatients
with bipolar disorder) [40] using DSM-IV criteria and
0.2 % (in a sample of adult female twins) [42] to 3.6 % (in
a sample of first degree relatives of BED patients) [21]
using the proposed DSM-5 criteria.
In three studies the lifetime prevalence of BED (DSM-
IV) was 1.5–6 times higher in women than in men [3, 4, 21].
Hudson et al. [21]. found no difference in the proportion of
women and men regarding the DSM-IV and the proposed
DMS-5 lifetime prevalence of BED (Online Resource 2).
Sex difference was also observed in point and 12-month
prevalence rates (Online Resource 2). The majority of BED
cases occurred first in people’s lives between the ages of
12.4 and 24.7 years [3, 4, 16, 43]; however, the prevalence
of BED continued to rise until 40 years old [3]. From the
reviewed articles information on ethnic or racial differences
in prevalence of BED was limited and inconsistent. Azar-
bard et al. [24] found no significant differences in the
prevalence of BED among Hispanic, African American and
White women (Online Resource 2). However, Perez et al.
[14] reported higher prevalence for BED among Hispanic
(2.3 %) and Black individuals (1.6 %) compared to White
individuals (1.0 %).
Several studies examined the association of BED with
physical and psychiatric comorbidities. In the study Kessler
et al. [2] the odds ratio (OR) for BED was 2.9 for indi-
viduals with diabetes, 2.2 for hypertension, 1.6 for stroke
and 1.3 for heart disease (population-based estimates).
Point prevalence of BED (DSM-IV) in overweight/obese
individuals was reported to be 5.9 % in a sample with
serious mental illness [30], 13.4 % in a sample waiting for
bariatric surgery [39] and 23.9 % in a sample seeking
weight loss treatment [34]. The OR for lifetime BED was
0.7 for BMI \ 18.5, 1.0 for BMI 18.5–24.9, 1.3 for BMI
25–29.9, 3.1 for BMI 30–34.9, 3.0 for BMI 35–39.9 and
6.6 for BMI [ 40 (population-based estimates) [2]. Life-
time prevalence of BED was found to be elevated in
patients with obsessive–compulsive disorder and bipolar I
or II disorders [36, 40]. Compared to a non-eating disorder
group, the mean scores in Beck anxiety inventory was
higher for the BED group (23 vs. 13, p \ 0.001) and for the
Beck depression inventory (23 vs. 15, p \ 0.001) [36].
Several studies reported that BED occurred in a significant
number of women during pregnancy (1.8–7 %) and in the
post-partum period (2.7–3.1 %) [12, 27, 28, 32].
Mortality for BED was not reported in any of the
included studies and only 3 studies described data on sui-
cide attempt and/or ideation in BED patients [4, 22, 44].
When comparing asymptomatic and BED individuals,
among a school-based sample of youth the ORs for suicidal
ideation and attempt were 2.6 and 3.1, respectively [22]. In
the studies conducted by Carano et al. [44] and Swanson
et al. [4], 27.5 % (in adults) to 34.4 % (in adolescents) of
individuals with BED had suicidal ideations and the fre-
quency of suicidal attempts was 12.5 % (in adults) to
15.1 % (in adolescents).
Health-related quality of life burden
Sixteen studies reported data on the HRQoL burden of
BED (Table 1) [10, 11, 14, 15, 18, 19, 34, 43, 45–
52].Various questionnaires were used to measure HRQoL
in the studies. All but one study used validated HRQoL
questionnaires (Table 1). Perez et al. [14] used a self-
developed instrument. General HRQoL measures included
the Extended Satisfaction With Life Scale (ESWLS) [10],
EuroQol Five Dimensional Questionnaire (EQ-5D-3L)
[43], Short Form-36 (SF-36) [11, 19, 45–48, 50], Short
Form-12 (SF-12) [49] or World Health Organization Brief
Quality of Life Assessment (WHOQOL-BREF) [15, 49].
The SF-36 (n = 7) was the most commonly used HRQoL
questionnaire. An obesity-specific measure was used in 5
studies (Impact of Weight on Quality of Life Lite
(IWQOL-LITE) [18, 45, 51, 52] and Obesity Related Well-
Being (ORWELL) [34]).
HRQoL of patients with BED was significantly lower
than in control subjects (Table 1) [14, 34, 45–47, 49, 51,
52]. BED was associated with marked impairment com-
pared to general population norms in both the physical
component summary (PCS) and the mental component
summary (MCS) scores of SF-36 (Masheb et al. [48]
PCSBED: 47.3, MCSBED: 39.7; Padierna et al. [50].
PCSBED: 36.5, MCSBED: 32.0 vs. PCSpopulation norm = 50.0,
MCSpopulation norm = 50.0). In the study conducted by
Grenon et al. [43] the EQ-5D-3L mean score of over-
weight/obese women with BED (0.77) was significantly
lower than for a US community sample of women with a
similar mean age (0.89).
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HRQoL data, baseline mean (SD)
Cassin [10]a ESWLS BED, AMI 54 ESWLS General life score: 16.5 (7.8), ESWLS
Social life score: 14.1 (8.0), ESWLS Sex life
score: 12.0 (8.0), ESWLS Self score: 14.1 (6.5),
ESWLS Physical appearance score: 7.1 (3.9),
ESWLS Family score: 19.5 (8.8), ESWLS
Relationships score: 17.5 (10.1)
BED, control (no AMI) 54 ESWLS General life score: 17.1 (8.0), ESWLS
Social life score: 15.8 (8.5), ESWLS Sex life
score: 13.5 (8.7), ESWLS Self score: 16.0 (6.9),
ESWLS Physical appearance score: 8.7 (4.9),
ESWLS Family score: 18.4 (10.1), ESWLS
Relationships score: 19.2 (9.3)
De Zwaan [45]b SF-36 BED, postoperative 9 SF-36 PCS: 42.2 (8.9), SF-36 MCS: 45.7 (10.4)
No BED, postoperative 69 SF-36 PCS: 47.2 (10.2), SF-36 MCS: 52.8 (7.8)
De Zwaan [46]b SF-36 BED, preoperative 19 SF-36 PCS: 31.1 (9.2), SF-36 MCS: 49.8 (10.1)
No BED, preoperative 91 SF-36 PCS: 28.1 (6.8), SF-36 MCS: 44.7 (9.5)
IWQOL-LITE BED, preoperative 19 IWQOL-LITE total score: 46.7 (17.6)
No BED, preoperative 91 IWQOL-LITE total score: 34.0 (9.9)
Doll [47]b SF-36 BED 18 SF-36 PCS: 46.3 (9.1), SF-36 MCS: 40.8 (9.0)
AN 6 SF-36 PCS: 43.4 (9.0), SF-36 MCS: 45.54 (8.9)
BN 45 SF-36 PCS: 47.2 (9.5), SF-36 MCS: 43.8 (9.4)
No ED 1,219 SF-36 PCS: 48.1 (16.7), SF-36 MCS: 49.8 (16.5)
Faulconbridge [11]a SF-36 BED, bariatric surgery 36 SF-36 PCS: 37.7 (1.7), SF-36 MCS: 43.1 (1.6)
BED, lifestyle modification 49 SF-36 PCS: 40.8 (1.3), SF-36 MCS: 45.4 (2.0)
Grenon [43]b EQ-5D-3L BED 105 EA-5D-3L index score: 0.77 (0.2)
Hsu [19]b SF-36 BED 37 SF-36 PCS: 33.0d, SF-36 MCS: 45.0d
Kolotkin [52]b IWQOL-LITE BED 95 IWQOL-LITE total score: 51.5 (21.9)
No BED 435 IWQOL-LITE total score: 65.3 (19.8)
Masheb [48]b SF-36 BED 94 SF-36 PCS: 47.3 (10.2), SF-36 MCS: 39.7 (11.0)
BED, BMI C 30 71 SF-36 PCS: 45.3 (9.6), SF-36 MCS: 39.3 (10.6)
BED, BMI \ 30 23 SF-36 PCS: 53.6 (9.4), SF-36 MCS: 41.0 (12.2)
Mond [49]b SF-12 BED 10 SF-12 PCS: 40.2 (13.1), SF-12 MCS: 30.4 (8.0)
AN, restricting type 19 SF-12 PCS: 45.4 (10.3), SF-12 MCS: 38.4 (11.1)
AN, purging type 15 SF-12 PCS: 46.8 (10.0), SF-12 MCS: 27.0 (7.4)
BN 40 SF-12 PCS: 49.3 (10.1), SF-12 MCS: 27.6 (9.4)
Normal control (no ED) 495 SF-12 PCS: 50.7 (8.8), SF-12 MCS: 47.4 (10.3)
WHOQOL-BREF BED 10 WHOQOL-BREF QoLP: 2.2 (0.5), WHOQOL-
BREF QoLS: 2.2 (1.0)
AN, restricting type 19 WHOQOL-BREF QoLP: 2.7 (0.9), WHOQOL-
BREF QoLS: 3.6 (1.0)
AN, purging type 15 WHOQOL-BREF QoLP: 2.1 (0.7), WHOQOL-
BREF QoLS: 2.6 (1.1)
BN 40 WHOQOL-BREF QoLP: 2.4 (0.7), WHOQOL-
BREF QoLS: 3.1 (1.0)
Normal control (no ED) 495 WHOQOL-BREF QoLP: 3.7 (0.6), WHOQOL-
BREF QoLS: 3.7 (0.8)
Padierna [50]b SF-36 BED 17 SF-36 PCS: 36.5d, MCS: 32.0d
AN, restricting type 56 SF-36 PCS: 44.0d, SF-36 MCS: 34.0d
AN, purging type 60 SF-36 PCS: 43.5d, SF-36 MCS: 28.0d
BN 64 SF-36 PCS: 43.0d, SF-36 MCS: 30.0d
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Where studies evaluated HRQoL for the different eating
disorders, there were no significant differences among AN,
BN and BED (Table 1) [47, 49, 50]; but, decreased phys-
ical HRQoL appeared to be most evident in patients with
BED. In the study by Mond et al. [49] physical health
measured by SF-12 was poorer in BED (PCS: 40.2) than in
AN (PCSrestricting type: 45.4, PCSpurging type: 46.8) and BN
(PCS: 49.3); however, most BED patients were obese
(BMI C 30) and had a higher mean age in that patient
group [mean age (standard deviation); AN restricting type:
19.31 (4.22); AN purging type: 25.53 (9.77); BN: 23.48
(6.25); BED: 34.33 (7.37)]. These findings were consistent
with those of Padierna et al. [50], who reported more
impaired physical health (SF-36) in BED patients (PCS:
36.5); nevertheless the differences compared to AN
(PCSrestricting type: 44.0, PCSpurging type: 43.5) and BN (PCS:
43.0) were not statistical significant (Padierna et al. [50]
presented their results only in figure form, SF-36 scores
were extracted from the figure).
Among subgroups of BED, obese BED patients had
significantly worse HRQoL than non-obese BED patients
(Table 1) [14, 34, 49]. In addition, BED was associated
with more impairment in HRQoL than obesity without
BED (IWQOL-LITE BED: 74.0 vs. No BED: 61.2; higher
scores indicating greater impairment) [51]. Obesity status
more strongly affected the physical dimension of HRQoL,
whereas BED status affected mental health and social
functioning HRQoL [14]. Among BED patients, obese
BED subjects (PCS: 45.3) had significantly lower scores in
PCS scores on the SF-36 compared to non-obese (PCS:
53.6) [48]. Depressive symptoms were also reported to be
significantly associated with lower HRQoL in patients with
BED (measured with EQ-5D-3L, after controlling for age
and BMI) [43].
Economic burden
Healthcare utilization in BED was assessed only in 8
studies [2–4, 13, 43, 53–55]. Healthcare costs were
reported only in two studies [43, 53]. Reported healthcare
utilization and healthcare costs data are presented in
Table 2 and Table 3.
Striegel-Moore et al. [55] analyzed the healthcare uti-
lization in women with BED using emergency room visits,
outpatient physician visits for medical care, outpatient
psychotherapy visits and days spent in the hospital over the
last 12 months. Compared to healthy individuals (mean








HRQoL data, baseline mean (SD)
Perez [14]c self-developed Non-obese without BED 12,063 Physical health score: 2.6 (0.7), Mental health score:
2.2 (1.0)
Non-obese with BED 124 Physical health score: 2.5 (0.8), Mental health score:
2.5 (1.2)
Obese without BED 4,585 Physical health score: 2.6 (0.8), Mental health score:
2.2 (1.0)
Obese with BED 126 Physical health score: 2.4 (0.8), Mental health score:
2.8 (1.1)
Ricca [34]b ORWELL BED 105 ORWELL total score: 54.3 (21.2)
BED subthreshold 146 ORWELL total score: 53.0 (20.3)
Overweight non-BED 187 ORWELL total score: 56.0 (22.2)
Rieger [51]b IWQOL-LITE BED 56 IWQOL-LITE total score: 74.0 (19.3)
No BED 62 IWQOL-LITE total score: 61.2 (26.3)
Silveria [15]a WHQOL-BREF BED 9 n.r.
Wilfley [18]a IWQOL-LITE BED, sibutramine 152 IWQOL-LITE total score: 67.7 (18.2)
BED, placebo 152 IWQOL-LITE total score: 68.7 (18.5)
AMI adapted motivational interviewing, AN anorexia nervosa, BED binge eating disorder, BN bulimia nervosa, ESWLS Extended Satisfaction
With Life Scale, EQ-5D-3L EuroQol Five Dimensional Questionnaire, HRQoL health-related quality of life, IWQOL-LITE Impact of Weight on
Quality of Life–Lite, MCS mental component summary, n.r. not reported, ORWELL obesity related well-being, PCS physical component
summary, QoLP psychological health, QoLS social relationships, SD standard deviation, SF-12 Short-Form Disability Scale, SF-36 Short Form
36, WHOQOL-BREF World Health Organization Brief Quality of Life Assessment Scale
a Longitudinal study
b Cross-sectional study
c Retrospective data analysis
d HRQoL data were presented only in figure form, HRQoL data were extracted from the figure
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Table 2 Selected healthcare utilization data for patients diagnosed with binge eating disorder
First author, reference Sample size Reported healthcare utilization data
Dickerson [53] BED sample (n): 50 % with any use
Weight- and eating disorder-related services 24
Non-weight- and eating disorder-related mental health services 24
Other provider-based services 100
Mental health medication services 62
Total medication services 90
Total health services 100
Grenon [43] BED sample (n): 105 % of participants endorsing each health care domain
Family physician visits 82
Medication use 72
Diagnostic tests 53





Emergency department visits 13
In-patient visits 2
Kessler [2] Total sample (n): 24,124
BED, lifetime prevalence: 1.9 %
Lifetime treatment for emotional problems (%) 58
12-month treatment for emotional problems (%) 37
Lifetime treatment for eating disorders (%) 38
12-month treatment for eating disorders (%) 10
Marques [13] Total sample (n): n.r.
BED, lifetime prevalence:
Lifetime any service use (%)
Latino: 2.1 % Non-Latino White 79
Non-Latino White: 1.4 % Latino 54
African American: 1.5 % Asian 55
Asian: 1.2 % African American 71
Mond [54] BED sample (n): 20 Lifetime service use (%)
Any treatment
Eating 58
General mental health 84
Weight 87
Treatment by a mental health professional
Eating 23
General mental health 39
Weight 45
Preti [3] Total sample (n): 21,425
BED, lifetime prevalence: 1.1 %
Lifetime access to service use for any emotional problem (%)
General medical 24
Psychiatrist 16
Other mental health 18
Non-medical professional 6
Complementary-alternative medical 12
Any lifetime treatment 39
12-month access to service use for any emotional problem (%)
General medical 17
Psychiatrist 10
Other mental health 3
Non-medical professional 10
Complementary-alternative medical 1
Any 12-month treatment 23
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increased total health service use (mean total service days:
11.8–21.4), but resource utilization in BED was similar to
other major psychiatric conditions (mean total service
days: 6.9–18.4) (Table 2). There was no significant dif-
ference in resource utilization between BED group and
non-eating Axis I psychiatric disorders group.
In the included studies, only a minority of BED patients
received treatment specifically for their eating disorder.
Swanson et al. [4] found that the lifetime service use for
treatment for eating or weight problems among BED
patients was only 11.9 %. In the study conducted by
Kessler et al. [2] 38.3 % of patients with a lifetime diag-
nosis of BED had received treatment specifically for an
eating disorder. Mond et al. [54] reported that in their study
sample, 58.1 % of BED patients had received treatment for
an eating problem, but 83.9 % received treatment for
general mental health and 87.1 % for weight loss. Only
12.9 % of BED patients were treated by a mental health
professional specifically for their eating disorder.
Marques et al. [13] examined mental health service
utilization for differences among ethnic groups. They
found mental health service use was higher for non-Latino
Whites (78.9 %) than for Latinos (54.1 %), Asians
(54.5 %) or African Americans (71.1 %).
The reported annual direct healthcare costs per BED
patient ranged from a low of $2,372 [43] to a high of
$3,731 [53] (Table 3). In one Canadian study [43], the
annual healthcare cost of overweight/obese women with
BED was 36.5 % higher than the estimated health expen-
diture per capita for women in the same age group. Another
US study [53] compared healthcare utilization between
women with BED (DSM-IV) and recurrent binge eating
(individuals with at least 1 day per week with an objective
bulimic episode over a 3-month period, with no periods of
binge free time greater than 2 weeks, and did not meet
DSM-IV criteria for BN or BED), and evaluated the effect
of the number of binge eating days on healthcare costs.
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Binge eating disorder (%) No-eating disorder (%)
Mental health specialty 60 29
General medicine 22 12
Human service 18 10
Complementary and alternative medicine 4 8
Juvenile justice 1 5
School service 20 21
Any treatment 73 44
Treatment specifically for eating or weight problems 11 n.a.
n.r. not reported, n.a. not applicable, SD standard deviation
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significantly in total annual healthcare costs adjusted for
age, BMI and self-reported depression.
Discussion
This systematic review of the epidemiology, and the
HRQoL and economic burden of BED consolidated exist-
ing data and provides a holistic overview of impact of BED
on public health. It also exposes the gaps in available data
where future studies might enable a better understanding of
the societal costs and overall burden of BED.
We analyzed 49 studies assessing the epidemiology,
economic and HRQoL burden of BED. The methodologi-
cal quality of the included studies was heterogeneous.
Issues related to statistical analysis such as sensitivity
analysis and addressing missing data were frequently
neglected.
Based on mixed-gender surveys, the lifetime prevalence
of BED appears to be about 1–2 %, with the 12-month
prevalence rate of 0.1–1 % in the general population
(DSM-IV) [2–4]. Point prevalence for BED was assessed in
many studies; however, the results of these prevalence
studies are difficult to compare because studies targeted
different study populations, and used different instruments
for screening for BED. Hudson et al. [1] reported that using
the proposed DSM-5 criteria instead DSM-IV criteria
might increase the lifetime prevalence of BED with 2.9 %
in women and 3.0 % in men. In consistent with these
findings, Trace et al. [42] also assessed higher lifetime
prevalence using the proposed DSM-5 criteria (DSM-IV:
0.17 % vs. proposed DSM-5: 0.20 %). BED appears to be
1.5–6 times more prevalent among females than males [3,
4, 21].BED can affect people of any age; but people in their
20s have higher risk than cohorts of other age groups [3].
BED is found to co-occur with several mental (anxiety,
depression, obsessive–compulsive disorder) and somatic
disorders (diabetes, hypertension) [2, 36, 40]. Pregnancy
and the post-partum period may be periods of particularly
high-risk for BED [12, 27, 28, 32]. Findings suggest that
pregnancy may not only facilitate the recurrence of BED,
but even contribute to its onset [28].
There have been no published studies investigating the
effects of BED on mortality, although it is comorbid with
disorders that are known to increase mortality risks. More
systematic assessment of the potential contribution of BED
status to mortality risks would be of value. Some research
did focus on suicidal ideations and attempts of patients
with BED [4, 22, 44]. This may suggest BED may be
associated with elevated levels of suicidal ideations and
even attempts compared to non-BED controls [22]. Sui-
cidal ideations in patients with BED appears to be 27.5 %
Table 3 Selected direct healthcare cost data for patients diagnosed with binge eating disorder
Reference Country, year
of pricing
Cost categories and reported costs Annual costs per
patient in 2012 $
Dickerson [53] US 2006 Binge eating disorder
Total costs mean (SD) $3,319 (4,050) $3,731
Weight- and eating disorder-related services mean (SD) $72 (176)
Non-weight- and eating disorder-related mental health
services mean (SD)
$415 (1,014)
Other provider-based services mean (SD) $1,925 (2,761)
Mental health medication services mean (SD) $411 (695)
Total medication services mean (SD) $906 (1,475)
Recurrent binge eatinga
Total costs mean (SD) $3,588 (4,665) $4,033
Weight- and eating disorder-related services mean (SD) $94 (299)
Non-weight- and eating disorder-related mental health
services mean (SD)
$341 (840)
Other provider-based services mean (SD) $2,221 (3,818)
Mental health medication services mean (SD) $301 (637)
Total medication services mean (SD) $933 (2,087)
Grenon [43] Canada 2009 Total costb (6-month) mean (SD) Can$1,379 (1,252) $2,372
Can$ Canadian dollar, $ United States dollar, SD standard deviation, US United States
a Individuals with at least 1 day per week with an objective bulimic episode over a 3-month period, with no periods of binge free time greater
than 2 weeks, and did not meet DSM-IV criteria for bulimia nervosa or binge eating disorder
b Family physician visits, medication use, diagnostic tests, health professionals’ visits, specialist visits, herbal remedies, other resources, out-
patient visits, emergency department visits, and in-patient visits
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(in adults) to 34.4 % (in adolescents) with the frequency of
suicidal attempts 12.5 % (in adults) to 15.1 % (in adoles-
cents) [4, 44].
Comorbid BED is a common problem in the obese
population [2]. Obesity, especially morbid obesity
(BMI [ 40) accounts for significant impairment in HRQoL
in BED [14, 34, 48]. Obesity is associated with diabetes,
hypertension, hypercholesterolemia, heart failure, ischemic
heart disease and may have severe health consequences
over time. Studies to increase understanding the long-term
burden of BED in these patients are needed. Currently we
lack data on the long-term health impact of BED. Obesity
is also related to the increased risk for mortality, and
though it may be difficult to quantify the net effect of BED
on obesity and on the consequential mortality, these are
important research questions.
BED significantly affects HRQoL. In BED, both phys-
ical and mental dimensions of HRQoL were significantly
below population norms, with the mental component
affected more [48, 50]. Compared to other eating disorders,
BED seemed to have lower (statistically not significant)
ratings in physical HRQoL [49, 50], which may be partially
accounted for by overweight status and poor physical
health [49].
Although BED is a prevalent eating disorder, there is
very limited literature examining the economic burden
(n = 8) of BED [2–4, 13, 43, 53–55]. Additionally,
available literature on its economic burden has used
inconsistent measures, limiting our ability to draw reliable
conclusions. BED is associated with a high rate of hospi-
talization, outpatient care, and emergency department use
[55]. BED patients rarely utilize the appropriate healthcare
services specifically for their eating disorder; patients
mostly receive treatment for general mental health and/or
weight loss [2, 4, 54]. This makes it difficult to sufficiently
gauge the relative impact of BED on these costs. This may
be partly explained in that healthcare providers have not
recognized BED as disorder requiring a specific treatment.
Improved diagnosis, awareness and treatment may even-
tually provide better data for estimating economic burden.
The annual direct healthcare cost in BED appears to be
higher than an age and sex matched national average [43].
Dickerson et al. [53] found no significant difference
between the annual healthcare costs of patients with BED
(DSM-IV) and recurrent binge eating.
The findings of this study should be considered in light
of the following limitations. Our systematic review iden-
tified only studies published in English, in peer-reviewed
journals that were indexed in the selected databases. In
order to get the most up to date data, the epidemiological
data were extracted only from studies published between
2009 and 2013 only. STROBE checklist was developed for
the quality assessment of observational studies in which
data were collected for the research purpose. Specific
issues related to research using routinely collected data are
not addressed in STROBE; nevertheless, we also used it for
assessing the quality of those studies in which retrospective
database analyses were performed. Included studies origi-
nated from 23 countries [with over half (n = 25) con-
ducted in the US]; however, because of the low number of
included articles, cultural differences could not be
addressed in this review. In this review we estimated the
occurrence of BED and did not study its determinants,
therefore confounding was not an issue. Nevertheless,
misclassification and selection bias might have occurred to
some extent, since not all the studies included used the
same diagnostic criteria, and the method of case ascer-
tainment was different.
In summary, BED has a lifetime prevalence rate of
1–2 % in the general population. BED significantly affects
HRQoL. It is associated with increased healthcare utiliza-
tion and healthcare costs compared to individuals without
an eating disorder. Obesity and especially morbid obesity
account for significant impairment in BED; however, the
negative health consequences of obesity can be more sig-
nificant on the long run. Only a minority of patients receives
a specific treatment for BED. With education of providers
on the diagnosis, reporting/coding, treatment, and man-
agement of BED, data should become available to permit
more accurate assessment of the HRQoL and economic
burden of this disorder. Future research (i.e., longitudinal
studies and randomized controlled trials) is needed to better
understand long-term consequences of BED and also help
with better management of this disorder.
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